Cloxazolam

DB01553ExperimentalSmall molecule

Cloxazolam is a benzodiazepine with anxiolytic, sedative/hypnotic, muscle relaxant, and antiepileptic effects. It is marketed in the Argentina, Australia, Portugal, Belgium, Switzerland, Luxembourg, Germany, Taiwan and Japan -- mainly for... The usual dose of cloxazolam in adults is 3-12mg/day for anti-anxiety.

Mechanism: Cloxazolam is a long acting benzodiazepine. It acts as a prodrug, with pharmacologically active metabolites, which bind to to the GABAa receptor, which other benzodiazepines bind to, to illicit a physiological response.
Curator reviewed
Primary indication: Used primarily as an anti-anxiety agent.Curator reviewed
Formula / weight: C₁₇H₁₄Cl₂N₂O₂ · 349.211 g/mol (avg)
Also known as: Cloxazolazepam
Code names: CS-370 · MT 14-411

Resolves to

Compound

UNIIGYL649Z0HYCAS24166-13-0ChEMBLCHEMBL2107254ChEBI31426PubChem2816KEGGD01268

Clinical / RWD

RxNorm21311ATCN05BA22

Structure

InChIKeyZIXNZOBDFKSQTC-UHFFFAOYSA-NSMILESClC1=CC2=C(NC(=O)CN3CCOC23C2=CC=CC=C2Cl)C=C1

What you can answer from here — as of September 16, 2026

2Protein targetsEach mapped to UniProt, with action and pharmacological action

Listed above

714Drug interactionsStructured to mechanism, not free text

5Marketed productsAcross 2 countries and 2 labellers

1ATC codeIncluding every combination product, plus 7 drug categories

9+ReferencesStructured and connected to the statements they support

Which companies are running trials of Cloxazolam, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account